- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Feb 18, 2022
Discovery & Translation
Engineered Wnt ligand restores BBB; plus Codiak, Autotac and more
BioCentury’s roundup of translational news
BioCentury | Oct 7, 2013
Finance
Altered Fate
Fate accepts IPO haircut, but now can reach Phase II inflection point
Items per page:
1 - 6 of 6